Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 819525, 8 pages
http://dx.doi.org/10.1155/2014/819525
Review Article

Recent Developments in Topical Wound Therapy: Impact of Antimicrobiological Changes and Rebalancing the Wound Milieu

Hautklinik Erlangen, Universitätsklinikum Erlangen, Ulmenweg 18, 91054 Erlangen, Germany

Received 4 November 2013; Revised 15 March 2014; Accepted 15 March 2014; Published 15 April 2014

Academic Editor: Paul J. Higgins

Copyright © 2014 Cornelia Erfurt-Berge and Regina Renner. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Gottrup, J. Apelqvist, and T. Bjarnsholt, “EWMA document: antimicrobials and non-healing wounds—evidence, controversies and suggestions,” Journal of Wound Care, vol. 22, pp. S1–S92, 2013. View at Google Scholar
  2. W. Dam, C. Winther, and G. S. Rasmussen, “Methods for cleaning and debridement of wounds—experiences with Debrisoft,” SAR, vol. 19, pp. 182–184, 2011. View at Google Scholar
  3. R. Strohal, “The EWMA document: debridement,” Journal of Wound Care, vol. 22, article 5, 2013. View at Google Scholar
  4. R. Renner, K. Seikowski, and J. C. Simon, “Association of pain level, health and wound status in patients with chronic leg ulcers,” Acta Dermato-Venereologica, vol. 94, no. 1, pp. 50–53, 2014. View at Publisher · View at Google Scholar
  5. F. Gottrup, B. Jørgensen, T. Karlsmark et al., “Reducing wound pain in venous leg ulcers with Biatain Ibu: a randomized, controlled double-blind clinical investigation on the performance and safety,” Wound Repair and Regeneration, vol. 16, no. 5, pp. 615–625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Arapoglou, K. Katsenis, K. N. Syrigos et al., “Analgesic efficacy of an ibuprofenreleasing foam dressing compared with local best practice for painful exuding wounds,” Journal of Wound Care, vol. 20, no. 7, pp. 319–325, 2011. View at Google Scholar · View at Scopus
  7. R. Renner, J. C. Simon, K. Seikowksi, and R. Treudler, “Contact allergy to modern wound dressings: a persistent but neglected problem,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 6, pp. 739–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Davies and M. Rippon, “Evidence review: the clinical benefits of Safetac technology in wound care,” Journal of Wound Care, supplement 3, pp. 3–31, 2008. View at Google Scholar · View at Scopus
  9. E. Lenselink and A. Andriessen, “A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds,” Journal of Wound Care, vol. 20, no. 11, pp. 534–539, 2011. View at Google Scholar · View at Scopus
  10. M. Briggs and E. A. Nelson, “Topical agents or dressings for pain in venous leg ulcers,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001177, 2003. View at Google Scholar · View at Scopus
  11. L. Huptas, N. Rompoti, S. Herbig et al., “A new topically applied morphine gel for the pain treatment in patients with chronic leg ulcers: first results of a clinical investigation,” Hautarzt, vol. 62, no. 4, pp. 280–286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ulubayram, A. N. Cakar, P. Korkusuz, C. Ertan, and N. Hasirci, “EGF containing gelatin-based wound dressings,” Biomaterials, vol. 22, no. 11, pp. 1345–1356, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Smiell, T. J. Wieman, D. L. Steed, B. H. Perry, A. R. Sampson, and B. H. Schwab, “Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies,” Wound Repair and Regeneration, vol. 7, no. 5, pp. 335–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Tan, R. Krishnaraj, and T. A. Desai, “Evaluation of nanostructured composite collagen—Chitosan matrices for tissue engineering,” Tissue Engineering, vol. 7, no. 2, pp. 203–210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Zhang and P. X. Ma, “Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures,” Journal of Biomedical Materials Research, vol. 52, no. 2, pp. 430–438, 2000. View at Publisher · View at Google Scholar
  16. S. P. Zhong, Y. Z. Zhang, and C. T. Lim, “Tissue scaffolds for skin wound healing and dermal reconstruction,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 2, no. 5, pp. 510–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Trovatti, N. H. C. S. Silva, I. F. Duarte et al., “Biocellulose membranes as supports for dermal release of lidocaine,” Biomacromolecules, vol. 12, no. 11, pp. 4162–4168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. H. Nguyen, Y. H. Kim, H. Y. Song, and B. T. Lee, “Nano Ag loaded PVA nano-fibrous mats for skin applications,” Journal of Biomedical Materials Research B: Applied Biomaterials, vol. 96, no. 2, pp. 225–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Shao and F. Vollrath, “Surprising strength of silkworm silk,” Nature, vol. 418, no. 6899, p. 741, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. S. C. Kundu, B. C. Dash, R. Dash, and D. L. Kaplan, “Natural protective glue protein, sericin bioengineered by silkworms: potential for biomedical and biotechnological applications,” Progress in Polymer Science, vol. 33, no. 10, pp. 998–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Nirmala, D. Kodrík, M. Žurovec, and F. Sehnal, “Insect silk contains both a Kunitz-type and a unique Kazal-type proteinase inhibitor,” European Journal of Biochemistry, vol. 268, no. 7, pp. 2064–2073, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. J. G. Hardy and T. R. Scheibel, “Composite materials based on silk proteins,” Progress in Polymer Science, vol. 35, no. 9, pp. 1093–1115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. B. Mandal and S. C. Kundu, “Cell proliferation and migration in silk fibroin 3D scaffolds,” Biomaterials, vol. 30, no. 15, pp. 2956–2965, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kanokpanont, S. Damrongsakkul, J. Ratanavaraporn, and P. Aramwit, “An innovative bi-layered wound dressing made of silk and gelatin for accelerated wound healing,” International Journal of Pharmaceutics, vol. 436, no. 1-2, pp. 141–153, 2012. View at Publisher · View at Google Scholar
  25. R. Dash, S. K. Ghosh, D. L. Kaplan, and S. C. Kundu, “Purification and biochemical characterization of a 70 kDa sericin from tropical tasar silkworm, Antheraea mylitta,” Comparative Biochemistry and Physiology B: Biochemistry and Molecular Biology, vol. 147, no. 1, pp. 129–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Inpanya, A. Faikrua, A. Ounaroon, A. Sittichokechaiwut, and J. Viyoch, “Effects of the blended fibroin/aloe gel film on wound healing in streptozotocin-induced diabetic rats,” Biomedical Materials, vol. 7, no. 3, Article ID 035008, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. B. Malafaya, G. A. Silva, and R. L. Reis, “Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications,” Advanced Drug Delivery Reviews, vol. 59, no. 4-5, pp. 207–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Engineering Silk for Medicine, 2013, http://www.spintec-engineering.de/spintec-engineering.de/Home_D.html.
  29. M. Bienert, N. Labude, R. Knüchel-Clarke et al., “Behandlung chronischer Wunden durch Seiden-Matrices mit integrierten Wachstumsfaktoren,” ZfW, 2013.
  30. A. Schneider, X. Y. Wang, D. L. Kaplan, J. A. Garlick, and C. Egles, “Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing,” Acta Biomaterialia, vol. 5, no. 7, pp. 2570–2578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Barrandon and H. Green, “Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-α and epidermal growth factor,” Cell, vol. 50, no. 7, pp. 1131–1137, 1987. View at Google Scholar · View at Scopus
  32. A. Buckley, J. M. Davidson, C. D. Kamerath, T. B. Wolt, and S. C. Woodward, “Sustained release of epidermal growth factor accelerates wound repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 21, pp. 7340–7344, 1985. View at Google Scholar · View at Scopus
  33. J. D. Franklin and J. B. Lynch, “Effects of topical applications of epidermal growth factor on wound healing. Experimental study on rabbit ears,” Plastic and Reconstructive Surgery, vol. 64, no. 6, pp. 766–770, 1979. View at Google Scholar · View at Scopus
  34. E. S. Gil, B. Panilaitis, E. Bellas, and D. L. Kaplan, “Functionalized silk biomaterials for wound healing,” Advanced Healthcare Materials, vol. 2, no. 1, pp. 206–217, 2013. View at Publisher · View at Google Scholar
  35. M. J. Carter, C. P. Fylling, and L. K. Parnell, “Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis,” Eplasty, vol. 11, article e38, 2011. View at Google Scholar
  36. D. L. Villela and V. L. C. G. Santos, “Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review,” Growth Factors, vol. 28, no. 2, pp. 111–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Martinez-Zapata, A. J. Martí-Carvajal, I. Solà et al., “Autologous platelet rich-plasma for treating chronic wounds,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD006899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Soo, W. W. Shaw, X. Zhang, M. T. Longaker, E. W. Howard, and K. Ting, “Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair,” Plastic and Reconstructive Surgery, vol. 105, no. 2, pp. 638–647, 2000. View at Google Scholar · View at Scopus
  39. A. B. Wysocki, L. Staiano-Coico, and F. Grinnell, “Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9,” Journal of Investigative Dermatology, vol. 101, no. 1, pp. 64–68, 1993. View at Google Scholar · View at Scopus
  40. E. A. Rayment, Z. Upton, and G. K. Shooter, “Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer,” The British Journal of Dermatology, vol. 158, no. 5, pp. 951–961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. D. G. Armstrong and E. B. Jude, “The role of matrix metalloproteinases in wound healing,” Journal of the American Podiatric Medical Association, vol. 92, no. 1, pp. 12–18, 2002. View at Google Scholar · View at Scopus
  42. U. K. Saarialho-Kere, “Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers,” Archives of Dermatological Research, vol. 290, supplement, pp. S47–S54, 1998. View at Google Scholar · View at Scopus
  43. C. Wiegand, U. Schönfelder, M. Abel, P. Ruth, M. Kaatz, and U. Hipler, “Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro,” Archives of Dermatological Research, vol. 302, no. 6, pp. 419–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Cullen, R. Smith, E. Mcculloch, D. Silcock, and L. Morrison, “Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers,” Wound Repair and Regeneration, vol. 10, no. 1, pp. 16–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Veves, P. Sheehan, and H. T. Pham, “A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers,” Archives of Surgery, vol. 137, no. 7, pp. 822–827, 2002. View at Google Scholar · View at Scopus
  46. B. Coulomb, L. Couty, B. Fournier et al., “A NOSF (Nano-Oligosaccharide Factor) lipido-colloid dressing inhibits MMP in an in vitro dermal equivalent model,” Wound Repair and Regeneration, vol. 16, pp. A66–A82, 2008. View at Google Scholar
  47. J. Schmutz, S. Meaume, S. Fays et al., “Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial,” International Wound Journal, vol. 5, no. 2, pp. 172–182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Meaume, F. Truchetet, F. Cambazard et al., “A randomized, controlled, double-blind prospective trial with a lipido-colloid technology-nano-oligosaccharide factor wound dressing in the local management of venous leg ulcers,” Wound Repair and Regeneration, vol. 20, pp. 500–511, 2012. View at Google Scholar
  49. S. Eming, H. Smola, B. Hartmann et al., “The inhibition of matrix metalloproteinase activity in chronic wounds by a polyacrylate superabsorber,” Biomaterials, vol. 29, no. 19, pp. 2932–2940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. R. J. Snyder, V. Driver, C. E. Fife et al., “Using a diagnostic tool to identify elevated protease activity levels in chronic and stalled wounds: a consensus panel discussion,” Ostomy Wound Management, vol. 57, pp. 36–46, 2011. View at Google Scholar
  51. R. J. Snyder, B. Cullen, and L. T. Nisbet, “An audit to assess the perspectives of US wound care specialists regarding the importance of proteases in wound healing and wound assessment,” International Wound Journal, vol. 10, no. 6, pp. 653–660, 2013. View at Publisher · View at Google Scholar
  52. F. Jockenhofer, H. Gollnick, K. Herberger et al., “Bacteriological pathogen spectrum of chronic leg ulcers: results of a multicenter trial in dermatologic wound care centers differentiated by regions,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 11, pp. 1057–1063, 2013. View at Google Scholar
  53. R. Renner, M. Sticherling, R. Ruger, and J. Simon, “Persistence of bacteria like Pseudomonas aeruginosa in non-healing venous ulcers,” European Journal of Dermatology, vol. 22, pp. 751–757, 2012. View at Google Scholar
  54. J. A. Michaels, W. B. Campbell, B. M. King et al., “A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial,” Health Technology Assessment, vol. 13, no. 56, pp. 1–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. R. G. Sibbald, P. Coutts, and K. Y. Woo, “Reduction of bacterial burden and pain in chronic wounds using a new polyhexamethylene biguanide antimicrobial foam dressing-clinical trial results,” Advances in Skin and Wound Care, vol. 24, no. 2, pp. 78–84, 2011. View at Google Scholar · View at Scopus
  56. T. Eberlein, G. Haemmerle, M. Signer et al., “Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds,” Journal of Wound Care, vol. 21, no. 1, pp. 12–20, 2012. View at Google Scholar · View at Scopus
  57. S. A. Ermolaeva, A. F. Varfolomeev, M. Y. Chernukha et al., “Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds,” Journal of Medical Microbiology, vol. 60, no. 1, pp. 75–83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. O. Lademann, A. Kramer, H. Richter et al., “Skin disinfection by plasma-tissue interaction: comparison of the effectivity of tissue-tolerable plasma and a standard antiseptic,” Skin Pharmacology and Physiology, vol. 24, no. 5, pp. 284–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Isbary, J. Heinlin, T. Shimizu et al., “Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial,” The British Journal of Dermatology, vol. 167, no. 2, pp. 404–410, 2012. View at Publisher · View at Google Scholar
  60. G. Isbary, G. Morfill, H. U. Schmidt et al., “A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients,” The British Journal of Dermatology, vol. 163, no. 1, pp. 78–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Heinlin, J. L. Zimmermann, F. Zeman et al., “Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites,” Wound Repair and Regeneration, vol. 21, no. 6, pp. 800–807, 2013. View at Publisher · View at Google Scholar
  62. G. Isbary, W. Stolza, T. Shimizu et al., “Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: Results of an open retrospective randomized controlled study in vivo,” Clinical Plasma Medicine, vol. 1, no. 2, pp. 25–30, 2013. View at Publisher · View at Google Scholar
  63. V. K. Shukla, D. Shukla, S. K. Tiwary, S. Agrawal, and A. Rastogi, “Evaluation of pH measurement as a method of wound assessment,” Journal of Wound Care, vol. 16, no. 7, pp. 291–294, 2007. View at Google Scholar · View at Scopus
  64. J. K. Chai, “The pH value of granulating wound and skin graft in burn patients,” Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi, vol. 8, no. 3, pp. 177–246, 1992. View at Google Scholar · View at Scopus
  65. S. D. Milne and P. Connolly, “The influence of different dressings on the pH of the wound environment,” Journal of Wound Care, vol. 23, pp. 53–57, 2014. View at Google Scholar
  66. S. Schreml, R. J. Meier, K. T. Weiss et al., “A sprayable luminescent pH sensor and its use for wound imaging in vivo,” Experimental Dermatology, vol. 21, no. 12, pp. 951–953, 2012. View at Publisher · View at Google Scholar
  67. D. Sharp, “Printed composite electrodes for in-situ wound pH monitoring,” Biosensors and Bioelectronics, vol. 50, pp. 399–405, 2013. View at Publisher · View at Google Scholar
  68. European Wound Management Association (EWMA), “Position document: management of wound infection,” 2006.
  69. K. F. Cutting and R. White, “Defined and refined: criteria for identifying wound infection revisited,” The British Journal of Community Nursing, vol. 9, no. 3, pp. S6–S15, 2004. View at Google Scholar · View at Scopus